Opioid receptor imaging with positron emission tomography and [18F]cyclofoxy in long-term, methadone-treated former heroin addicts

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 3, 2000, Pages 1070-1076

  Kling, Mitchel A ^c   Carson, Richard E ^b   Borg, Lisa ^a   Zametkin, Alan ^c   Matochik, John A ^e   Schluger, James ^a   Herscovitch, Peter ^b   Rice, Kenner C ^d   Ho, Ann ^a   Eckelman, William C ^b   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOFOXY; METHADONE; OPIATE RECEPTOR;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; FEMALE; HEROIN DEPENDENCE; HUMAN; IMMUNE RESPONSE; LONG TERM CARE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; THALAMUS;

ADULT; AGED; BRAIN; FEMALE; FLUORINE RADIOISOTOPES; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MIDDLE AGED; NALTREXONE; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033679983     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Variation in receptor function from a single nucleotide palymorphism in the human μ-opioid receptor gene: Possible implications for opioid addiction
2. Cocaine abuse sharply reduced in an effective methadone maintenance program
3. Probes for narcotic receptor mediated phenomena. II. Synthesis of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5 alpha-epoxy-6-beta-fluoromorphinans (foxy and cyclofoxy) as models of opioid ligands suitable for positron emission transaxial tomography
4. 18F]cyclofoxy and positron emission tomography
5. 18F]3-acetylcyclofoxy: A high affinity opiate antagonist
6. Opiate receptor avidity and cerebral blood flow in Alzheimer's disease
7. Narcotic blockade
8. Laminar distribution of the multiple opioid receptors in the human cerebral cortex
9. Pain perception in drug-free and in methadone-maintained haman ex-addicts
10. μ-Opioid receptor and α-2-adrenoreceptor agonist binding sites in the postmortem brain of heroin addicts
11. The levels of methadone in the plasma in methadone maintenance
12. μ-Opioid receptor internalization: Opiate drugs have different effects on a conserved endocytic mechanism in vitro and in the mammalian brain
13. Medical safety and side effects of methadone in tolerant individuals
14. Plasma and urine levels of methadone
15. Medical complications in methadone patients
16. Multiple drug abuse patterns and medical consequences
17. Rationale for maintenance pharmacotherapy of opiate dependence
18. Opiates, opioids and addiction
19. Opioid receptors: Some perspectives from early studies of their role in normal physiology, stress respensivity and in specific addictive diseases
20. Stereoselective disposition of methadone in man
21. Drug dependence: Stress and dysregulation of brain reward pathways
22. ACTH, cortisol and beta-endorphin response to metyrapene testing during chronic methadone maintenance treatment in humans
23. Effects of chronic exogenous opioid administration on levels of one endogenous opioid (betaendorphin) in man
24. A quantitative medal for the in rive assessment of drug binding sites with positron emission tomography
25. Natural killer ceil activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients
26. 18F]Acetylcyclofoxy: A useful probe for the visualization of opiate receptors in living animals
27. 3H]cyclofoxy: An opiate antagonist suitable for positron emission tomography
28. Human spinal fluid methadone levels
29. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: Implications for the treatment of alcoholism
30. 18F]cyclofoxy
31. Chronic cocaine alters brain μ-opioid receptors
32. Repeated cocaine administration upregulates κ- and μ-, but not δ-, opioid receptors
33. Rapid automated algorithm for aligning and reslicing PET images
34. Acute 'binge' cocaine increases μ-opioid receptor mRNA levels in areas of the rat mesolimbic mesocortical dopamine system
35. Steadystate methadone in rats does not change mRNA levels of corticotropin-releasing factor, its pituitary receptor or proopiomelanocortin
36. Increased μ-opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving